Pharmacoeconomic evaluation of different doses of Curosurf for treating neonatal acute respiratory distress syndrome Page No: 1139-1146

By: Na Wang, Lin Wang

Keywords: Neonates, respiratory distress syndrome, economic evaluation, surfactant

DOI : 10.36721/PJPS.2020.33.3.REG.1139-1146.1

Abstract: Neonatal acute respiratory distress syndrome (ARDS) is a serious stage of acute lung injury (ALI) which can be treated by exogenous surfactant



[View Complete Article]